ArticleCancers2025

ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing Sarcoma.

Jessica Gartrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.